Form 4 for ABT Abbott Laboratories
Accepted 2024-07-02 00:00:00 ET · period of report 2024-06-30 · accession 0001415889-24-018920 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-07-02 | 2024-06-30+ | ABT | Morrone Louis H. | EVP | F - Tax | $103.91 | -825 | 62.1K | -1% | -$85.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2024-06-30 | F | D | 269 | $103.91 | 62,699 | D | — | — | |
| 2 | Common | Common shares without par value | 2024-07-01 | F | D | 556 | $103.91 | 62,143 | D | — | — |